News
On his part, Madbouly emphasized that this meeting aims to follow up on efforts to advance the pharmaceutical industry ...
16h
GlobalData on MSNPharma CEOs downplay impact of tariffs amid rising cost concernsAnalysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.
Pharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the ...
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating ...
Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...
The Saudi Food and Drug Authority (SFDA) has approved Agios' Pyrukynd (mitapivat) for adults with alpha or beta-thalassemia.
President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...
The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.
Iraq's drug localization efforts save $1B annually, with 34 factories at full capacity & 178 new applications, says PM's ...
A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...
President Trump has imposed a 15 percent tariff on most items in a trade agreement with the European Union, with ...
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results